Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-04-05 09:47 am Purchase | 13G | ROCKET PHARMACEUTICALS INC RCKT | WELLINGTON MANAGEMENT GROUP LLP | 9,156,099 10.12% | 958,553 (+11.69%) | View |
| 2024-02-13 5:14 pm Purchase | 13G | ROCKET PHARMACEUTICALS INC RCKT | VANGUARD GROUP INC | 5,447,565 6.04% | 1,261,023 (+30.12%) | View |
| 2024-02-08 10:17 am Purchase | 13G | ROCKET PHARMACEUTICALS INC RCKT | WELLINGTON MANAGEMENT GROUP LLP | 8,197,546 9.09% | 4,690,529 (+133.75%) | View |
| 2024-01-29 3:26 pm Purchase | 13G | ROCKET PHARMACEUTICALS INC RCKT | BlackRock Inc. BLK | 5,930,178 6.6% | 342,643 (+6.13%) | View |
| 2024-01-22 11:43 am Sale | 13G | ROCKET PHARMACEUTICALS INC RCKT | STATE STREET CORP STT | 3,231,411 3.58% | -747,574 (-18.79%) | View |
| 2023-09-19 4:15 pm Unchanged | 13D | ROCKET PHARMACEUTICALS INC RCKT | RTW INVESTMENTS LP | 18,188,457 20.32% | 0 (Unchanged) | View |
| 2023-04-05 4:31 pm Purchase | 13D | ROCKET PHARMACEUTICALS INC RCKT | RTW INVESTMENTS LP | 18,188,457 23% | 559,890 (+3.18%) | View |
| 2023-02-09 11:32 am Purchase | 13G | ROCKET PHARMACEUTICALS INC RCKT | VANGUARD GROUP INC | 4,186,542 5.32% | 885,404 (+26.82%) | View |
| 2023-02-06 2:56 pm Purchase | 13G | ROCKET PHARMACEUTICALS INC RCKT | WELLINGTON MANAGEMENT GROUP LLP | 3,507,017 4.45% | 16,138 (+0.46%) | View |
| 2023-01-31 1:58 pm Purchase | 13G | ROCKET PHARMACEUTICALS INC RCKT | BlackRock Inc. BLK | 5,587,535 7.1% | 2,248,066 (+67.32%) | View |
| 2023-01-31 10:47 am Purchase | 13G | ROCKET PHARMACEUTICALS INC RCKT | STATE STREET CORP STT | 3,978,985 5.05% | 3,978,985 (New Position) | View |
| 2022-10-11 4:30 pm Purchase | 13D | ROCKET PHARMACEUTICALS INC RCKT | RTW INVESTMENTS LP | 17,628,567 24.4% | 1,355,932 (+8.33%) | View |
| 2022-09-21 09:00 am Unchanged | 13D | ROCKET PHARMACEUTICALS INC RCKT | RTW INVESTMENTS LP | 16,272,635 24.6% | 0 (Unchanged) | View |
| 2022-02-14 5:18 pm Sale | 13G | ROCKET PHARMACEUTICALS INC RCKT | PERCEPTIVE ADVISORS LLC | 1,959,125 3% | -1,437,742 (-42.33%) | View |
| 2022-02-14 4:00 pm Sale | 13G | ROCKET PHARMACEUTICALS INC RCKT | TANG CAPITAL PARTNERS LP | 2,531,800 3.9% | -433,685 (-14.62%) | View |
| 2022-02-14 2:34 pm Sale | 13G | ROCKET PHARMACEUTICALS INC RCKT | PRICE T ROWE ASSOCIATES INC | 2,192,894 3.4% | -1,286,427 (-36.97%) | View |
| 2022-02-10 08:37 am Purchase | 13G | ROCKET PHARMACEUTICALS INC RCKT | VANGUARD GROUP INC | 3,301,138 5.12% | 3,301,138 (New Position) | View |
| 2022-02-04 4:12 pm Purchase | 13G | ROCKET PHARMACEUTICALS INC RCKT | BlackRock Inc. BLK | 3,339,469 5.2% | 3,339,469 (New Position) | View |
| 2022-02-04 09:22 am Purchase | 13G | ROCKET PHARMACEUTICALS INC RCKT | WELLINGTON MANAGEMENT GROUP LLP | 3,490,879 5.42% | 3,490,879 (New Position) | View |
| 2021-08-31 5:08 pm Purchase | 13D | ROCKET PHARMACEUTICALS INC RCKT | RTW INVESTMENTS LP | 16,272,635 25.3% | 87,516 (+0.54%) | View |